← Back to Search

Fat Grafting for Breast Reconstruction

N/A
Waitlist Available
Led By Christin A Harless, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Breast cancer patients undergoing immediate tissue expander or implant reconstruction requiring radiation therapy
Have undergone mastectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is measuring the effects of radiation and fat grafting on blood flow to post-mastectomy skin.

Who is the study for?
This trial is for breast cancer patients who have had a mastectomy and are undergoing immediate reconstruction with tissue expanders or implants that require radiation therapy. It's not open to those who do not wish to participate.Check my eligibility
What is being tested?
The study is looking at how well blood flows through the skin of the breast after it has been treated with radiation and then fat grafting. This will help understand if fat grafting improves skin condition post-radiation.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks associated with fat grafting may include infection, bleeding, or changes in sensation around the treatment area.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a breast cancer patient getting an implant or tissue expander with planned radiation therapy.
Select...
I have had a mastectomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Radiation Fibrosis

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Breast reconstruction with fat graftingExperimental Treatment1 Intervention
fat grafting
Group II: breast reconstruction without fat graftingActive Control1 Intervention
No Fat grafting
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fat grafting
2011
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,734 Total Patients Enrolled
Christin A Harless, MDPrincipal InvestigatorMayo Clinic

Media Library

Fat grafting Clinical Trial Eligibility Overview. Trial Name: NCT04992650 — N/A
Breast Reconstruction Research Study Groups: Breast reconstruction with fat grafting, breast reconstruction without fat grafting
Breast Reconstruction Clinical Trial 2023: Fat grafting Highlights & Side Effects. Trial Name: NCT04992650 — N/A
Fat grafting 2023 Treatment Timeline for Medical Study. Trial Name: NCT04992650 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still accepting participants?

"The information on clinicaltrials.gov indicates that this trial is not presently enrolling patients; the study was initially published on March 1st 2021 and its status last changed in December of that same year. However, there are currently 262 other medical trials searching for participants."

Answered by AI
~13 spots leftby Jun 2025